MGRX vs ROK · rev $456.0K vs P/E 48, rev $8.34B
Mangoceuticals, Inc. Common Stock (MGRX) versus Rockwell Automation Inc (ROK) — a side-by-side from cached financials, not a winner call.
Mangoceuticals, Inc. Common Stock (MGRX) is a health information services company listed on US.
Rockwell Automation Inc (ROK) is a specialty industrial machinery company listed on NYSE.
Latest reported MGRX revenue for 2025-12-31 was $456.0K. Net income was -$20.6M. Revenue was down 26.0% from 2024-12-31 to 2025-12-31. MGRX currently screens at market cap $16.3M.
Latest reported ROK revenue for 2025-09-30 was $8.34B. Net income was $749.0M. ROK currently screens at market cap $51.04B and trailing P/E 47.5.
MGRX currently screens at market cap $16.3M. ROK currently screens at market cap $51.04B and trailing P/E 47.5.
Not investment advice. Open the MGRX and ROK stock pages for the full models.
Not investment advice.